Drugs / IFN-gamma
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01147042 Comparator | May 2010 → Nov 2014 | chronic granulomatous disease, immunodeficiency disease | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IFN-gamma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01147042 ↗ |
| Route | Subcutaneous | “have a subcutaneous injection of 50 mcg per meter squared” NCT01147042 ↗ |